Post-stroke upper limb dyskinesia
Conditions
Interventions
G1:The rTMS sham stimulation was given on the basis of conventional rehabilitation treatment, first to the cerebellar hemisphere contralateral to the lesion and then immediately to the M1 area of the
G2:The rTMS treatment was given on the basis of the conventional rehabilitation treatment. rTMS was first used to stimulate the contralateral cerebellar hemisphere of the lesion, followed immediately
G3:The rTMS treatment was given on the basis of the conventional rehabilitation treatment. rTMS was first used for sham stimulation of the cerebellar hemisphere on the contralateral side of the lesion
G4:The rTMS treatment was given on the basis of conventional rehabilitation therapy. rTMS was first used to stimulate the contralateral cerebellar hemisphere of the lesion, followed immediately by sti
Sponsors
The First Affiliated Hospital of Gannan Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) Age =18 years, gender is not limited; (2) Patients with first onset of cerebral hemorrhage or cerebral infarction in one cerebral hemisphere confirmed by CT/MRI; (3) Time of onset > 2 weeks, with stable vital signs; (4) Patients with unilateral upper limb dysfunction and Fulg-Meyer upper limb score <60; (5) The patients or their immediate family members were able and willing to sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cardiac, pulmonary, hepatic and renal insufficiency; (2) Upper limb dysfunction secondary to other diseases; (3) Patients with a history of epilepsy; (4) Contraindications to transcranial magnetic therapy such as cranial defects or intracranial metal built-in objects, high intracranial pressure and so on; (5) Pregnant or lactating women; (6) Those who are participating in other clinical studies or have participated in other clinical studies within 3 months before admission; (7) Patients with poor compliance and inability to cooperate with evaluation and treatment; (8) Other patients deemed by the investigator to be unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment-Upper Extremity; | — |
Secondary
| Measure | Time frame |
|---|---|
| modified Ashworth scale;Modified Barthel Index;Functional near infra-red spectroscopy; | — |
Countries
China
Contacts
Public ContactYun Luo
Department of Rehabilitation, The First Affiliated Hospital of Gannan Medical University, Ganzhou City, Jiangxi Province, China
Outcome results
None listed